Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001871155-24-000003
Filing Date
2024-10-04
Accepted
2024-10-04 16:02:12
Documents
4
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1728072124.html 3  
1 FORM 3 wk-form3_1728072124.xml 3 8419
2 EX-24 crbu-xsection16poa_fisch.htm EX-24 4255
3 crbu-xsection16poa_fisch001.jpg GRAPHIC 205159
4 crbu-xsection16poa_fisch002.jpg GRAPHIC 33754
  Complete submission text file 0001871155-24-000003.txt   343335
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CARIBOU BIOCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Fischesser Ryan (Reporting) CIK: 0001871155 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40631 | Film No.: 241354879